$GRI tap tap tapping $2.2 resistanceNASDAQ:GRI will release topline 12-week study data this week. All indications are that data will be positive. The price continues to test $2.2 resistance. This will be broken soon.
While all price movements are relative and unique, other companies with failed IPF trials lost ~$300M in market cap upon announcement. Others with successful trails have gained billions. GRI is worth approximately $6M today. Lots of room for upward valuation.
